Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients

NCT00873353 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Adenocarcinoma of the Pancreas

Interventions

DRUG: capecitabine + erlotinib

Sponsor

Grupo Gallego de Investigaciones Oncologicas